Catalytica Pharmaceuticals Inc., CV Therapeutics deal

Catalytica Pharmaceuticals, a subsidiary of Catalytica Inc., will manufacture Ranolazine piperazine actamide sustained release tablets for use in CVTX's U.S. Phase III angina trials. Catalytica also ...